NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
出版年份 2022 全文链接
标题
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
作者
关键词
-
出版物
Journal of Clinical Lipidology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-06-10
DOI
10.1016/j.jacl.2022.05.068
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prevalence of statin intolerance: a meta-analysis
- (2022) Ibadete Bytyçi et al. EUROPEAN HEART JOURNAL
- Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance
- (2021) Andrey V. Susekov et al. CARDIOVASCULAR DRUGS AND THERAPY
- Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
- (2021) Emily Herrett et al. BMJ-British Medical Journal
- Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction
- (2021) R. Preston Mason et al. AMERICAN JOURNAL OF MEDICINE
- Umbrella Review on Non-Statin Lipid-Lowering Therapy
- (2021) Semira Abdi Beshir et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- (2021) Camilla Ditlev Lindhardt Johannesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- RNA Silencing in the Management of Dyslipidemias
- (2021) Neil C. Henney et al. Current Atherosclerosis Reports
- Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
- (2021) James P. Howard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combination lipid-lowering therapy as first-line strategy in very high-risk patients
- (2021) Kausik K Ray et al. EUROPEAN HEART JOURNAL
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
- (2021) Nicholas A. Marston et al. JAMA Cardiology
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
- (2020) Tom G. Richardson et al. PLOS MEDICINE
- Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets
- (2020) Lluís Masana et al. Current Cardiology Reports
- Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance
- (2020) Stephen J Nicholls et al. AMERICAN HEART JOURNAL
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statin Toxicity
- (2019) Natalie C. Ward et al. CIRCULATION RESEARCH
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Management of Statin Intolerance
- (2019) Rodrigo Alonso et al. Journal of Atherosclerosis and Thrombosis
- The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
- (2019) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
- (2019) Christie M Ballantyne et al. European Journal of Preventive Cardiology
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
- (2019) Yasuyoshi Ouchi et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey
- (2018) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Peter W.F. Wilson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Niacin and heart disease prevention: Engraving its tombstone is a mistake
- (2017) Harold Robert Superko et al. Journal of Clinical Lipidology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
- (2016) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
- (2016) Maciej Banach et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The nocebo effect in the context of statin intolerance
- (2016) Jonathan A. Tobert et al. Journal of Clinical Lipidology
- Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
- (2016) Kevin C. Maki et al. Journal of Clinical Lipidology
- 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2016) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
- (2015) Maciej Banach et al. Archives of Medical Science
- Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study
- (2015) Sune Fallgaard Nielsen et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
- (2014) Mary A. De Vera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An assessment by the Statin Intolerance Panel: 2014 update
- (2014) John R. Guyton et al. Journal of Clinical Lipidology
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
- (2013) Warner M. Mampuya et al. AMERICAN HEART JOURNAL
- Discontinuation of Statins in Routine Care Settings
- (2013) Huabing Zhang et al. ANNALS OF INTERNAL MEDICINE
- Effect of Statins on Skeletal Muscle Function
- (2012) Beth A. Parker et al. CIRCULATION
- Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
- (2012) Jerome D. Cohen et al. Journal of Clinical Lipidology
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance
- (2011) Charles J. Glueck et al. CURRENT MEDICAL RESEARCH AND OPINION
- Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence
- (2011) Yessica-Haydee Gomez Sandoval et al. CURRENT PHARMACEUTICAL DESIGN
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
- (2009) Vivian A. Fonseca et al. DIABETES OBESITY & METABOLISM
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started